and cnn tonight. jake? thanks, anderson. welcome to cnn tonight, i m jake tapper in washington. tonight we are bringing you a cnn exclusive. brand-new video you will see right here for the very first time in just a few moments. it is really, i have to tell you, an incredible story, one that only cnn s clarissa ward can tell. it s taking place during a rare cease-fire in putin s brutal war, giving two hours of cover for this traumatic scene. cnn crews shuttled by ukrainian intelligence as russia returned the body of an american, an american killed in ukraine while fighting for ukraine. his name was joshua jones. he was 24 years old, a u.s. army veteran from tennessee. he was killed in august 12 fighting putin s forces alongside the ukrainian military. this handover happened after months of negotiations in a dangerous area known as no-man s-land. it s in the zaporizhzhia region between ukrainian-controlled ukraine and russian-controlled ukraine. and jones s body will now head
Have a professional history. He didnt need to mention everyone agrees. Mueller in the letter the way he the manner in which theyre in a did. Box is they have to decide if mueller finished tonight. Did you see any evidence, clues, the crime of Obstruction Of Justice and Witness Tampering anything like that because youve been on the ground . And others, if thats still illegal. If they still think its a crime. I think the letter codified the Personality Traits we have already seen from this new Attorney General as weve been waiting for this report to be has donald trump given them a delivered here to him. He stayed calm. Taken way in congress. We saw him around the Justice Department. He eats lunch with the staff and cafeteria, the Justice Department which is not normally so we have mtp beat. Anything you recommend if you have a nice lunch. He eats with staff every day around noon. He seems to stick to a schedule. Actually thought you were he sees reporters in the leaving. Hallway. He may
Faculty offer expert insights into emerging data on BTK inhibitor resistance in CLL, referencing earlier findings that indicate the potential existence of mutations before BTK inhibitor exposure and the process of clonal selection.
Richard Furman, MD, outlines his strategy for addressing BTK inhibitor intolerance in CLL patients, underscoring the significance of BTK inhibitors in CLL treatment and advocating for transitioning to an alternative BTK inhibitor rather than completely discontinuing the class in cases of drug intolerance.